[1]
J. Vera, “Real-World Effectiveness and Safety of Glecaprevir/Pibrentasvir for the Treatment of Chronic Hepatitis C: A Prospective Cohort Study in Portugal”, Acta Med Port, vol. 37, no. 5, pp. 323–333, Feb. 2024.